atalo
Uploaded by
11 SLIDES
244 VUES
110LIKES

Innovative HIV Management Strategies: A Case Study of a 46-Year-Old Male Patient

DESCRIPTION

This detailed case presentation explores the evolving management of a 46-year-old male diagnosed with HIV in 2006. It highlights key medical insights, including initial CD4 count, viral load, and genetic testing results. The progression of treatment is documented over several years, focusing on therapy regimens involving TDF/FTC and various protease inhibitors, while also addressing challenges such as GI intolerance, abnormal lipid levels, and renal function changes. This case serves as a resource for HIV-related medical communication and innovative treatment strategies.

1 / 11

Télécharger la présentation

Innovative HIV Management Strategies: A Case Study of a 46-Year-Old Male Patient

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VIRTUAL MEDZONE Your Resource for HIV Related Innovative Medical Communication

  2. CASE PRESENTATIONS Chris Steingart MD FRCPC John MacLeod MD CCFP David Fletcher MD FRCPC

  3. CASE 1 • 46 y.o. man • HIV+ 2006 • CD4 290 • HIV VL 59,246 • HLAB5701 positive

  4. CASE 1 BASELINE GENOTYPE

  5. CASE 1 WHAT WOULD YOU TREAT WITH?

  6. CASE 1 2007 TDF+FTC/Lopinavir/RTV initiated • CD4 290 increased to 400 • HIV VL <50

  7. CASE 1 2007-2008 TDF+FTC/Lopinavir/RTV • GI Intolerance • Triglycerides 11.5 mmol/l despite optimal management • Cholesterol 8 mmol/l … LDL ? • Previously normal lipids WHAT WOULD YOU DO?

  8. CASE 1 2008 TDF+FTC/RTV/Atazanavir • Jaundice • Lipids remain abnormal and unchanged!!! WHAT WOULD YOU DO?

  9. CASE 1 2009 TDF+FTC/RTV/Darunavir • Lipids remain abnormal • ’d albumin/creatinine ratio to 90 (N<2) • 24 hr urine 2.534 g/day (N<250 mg) • 24 hr creatinine clearance 60 ml/min (N>97 ml/min) WHATS GOING ON? WHAT WOULD YOU DO?

  10. CASE 1 2009/10 Tropism R5 3TC/Etravirine/Maraviroc/Raltegravir • CD4 540-610 HIV VL <50 x 3 • Cholesterol 3.83 mmol/l • LDL 1.68 mmol/l

  11. CASE 1 2009/10 3TC/Etravirine/Maraviroc/Raltegravir Albumin/creatinine ratio… 1 24 hr urine protein…150mg/day 24 hr creatinine clearance… 96 ml/min

More Related